4//SEC Filing
Reich Kristian 4
Accession 0001213900-25-019673
CIK 0001821586other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 9:07 PM ET
Size
5.6 KB
Accession
0001213900-25-019673
Insider Transaction Report
Form 4
Reich Kristian
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-27+139,273→ 139,273 totalExercise: $41.77Exp: 2035-02-27→ Class A ordinary shares, par value $0.0001 per share (139,273 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 139,273 of the Issuer's Class A ordinary shares, vesting in four equal annual installments on February 27, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
Documents
Issuer
MoonLake Immunotherapeutics
CIK 0001821586
Entity typeother
Related Parties
1- filerCIK 0001920553
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 9:07 PM ET
- Size
- 5.6 KB